Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gemma Medcalf

Roche Basel Switzerland

Patient death mars Roche haemophilia drug trial

Increases concerns over emicizumab’s safety profile with drug on course to file later this year

- PMLiVE

Riding the wave of digital disruption

The challenges and rewards of meeting consumer expectations

- PMLiVE

EFPIA appoints new director general

Nathalie Moll takes up the role from April

- PMLiVE

J&J’s clinical research neuroscience director joins MedAvante

Dr Michael Ropacki becomes head of R&D at the clinical data service

- PMLiVE

Mundipharma to launch first MabThera biosimilar in EU

EMA approves Truxima in all indications licensed to Roche’s cancer drug

- PMLiVE

Novartis’ Zykadia nears first-line lung cancer label

Hopes to boost slow second-line sales to compete directly with Pfizer’s Xalkori and Roche’s Alecensa 

- PMLiVE

Argos hit as kidney cancer immunotherapy fails phase III trial

Study discontinued as data shows renal cell carcinoma vaccine unlikely to meet targets

Rise of the patient expert – an interview with Michael Seres

Founded by Michael Seres in 2011, 11 Health is a connected medical device company currently working to change the lives of patients using stoma bags. Content Marketing Manager Liz Inskip...

Blue Latitude Health

- PMLiVE

The beauty and the beast of customer experience

Pharma’s ability to define, and more importantly, deliver customer experience may just determine where business is won or lost

BMS appoints three independent directors

Robert Bertolini, Matthew Emmens and Theodore Samuels join the board

Dr Catherine Strader joins Acorda Therapeutics’ board

She brings experience from Merck & Co and Synergy Partners R&D Solutions

Making sense of Nutraceuticals in China

Published in eyeforpharma February 2017 by Marc Yates

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links